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1. Introduction  
Human dentin autograft was reported in 2003 as a first clinical case (Murata et al., 2003), 
while human bone autograft was done in 1820. There was a long-long time lag between the 
autografts of dentin and bone. In 2009, Korea Tooth Bank was established in Seoul for the 
processing of the tooth-derived materials in Seoul, and an innovative medical service has 
begun for bone regeneration. Recently, the tooth-derived materials have been becoming a 
realistic alternative to bone grafting. 
The regeneration of lost-parts of the skeleton has been generally carried out with fresh, 
autogenous bone as a gold standard. To obviate the need for harvesting of grafts and thus, 
to avoid morbidity resulting from it, the researches for bone substitutes (Kuboki et al., 1995; 
Asahina et al., 1997; Takaoka et al., 1991; Artzi et al., 2004; Kim et al., 2010) or bone 
production via bio-engineering have begun (Wozney et al., 1988; Wang et al., 1990; Murata 
et al., 1999). In the regenerative field, there is a medical need for biomaterials that both allow 
for bone formation and also gradually absorb as to be replaced by bone. Non-absorbable 
materials are never replaced by bone and thus, reveal chronic inflammation in tissues as 
foreign bodies. 
As bone and dentin consist of fluid (10%), collagen (20%) and hydroxyapatite (70%) in 
weight volume, our attention for biomaterials is collagenous and ceramic materials (Murata 
et al., 2000; Murata et al., 2002; Akazawa et al., 2006; Murata et al., 2007). Generally, 
extracted teeth have been discarded as infective medical dusts in the world. We have 
thought the non-functional teeth as native resource for self and family (Fig. 1). Therefore, we 
noticed on bone-inductive, absorbable properties of dentin, and have been studying a 
medical recycle of human teeth as a novel graft material for bone regeneration in Japan and 
Korea (Akazawa et al. 2007; Kim et al. 2010). Biomaterial science should support and 
develop the advanced regenerative therapy using enamel and dentin matrix for patients in 
the near future. 
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In this chapter, human dentin will be introduced as novel biomaterial and also as carrier 
matrix of the recombinant human bone morphogenetic protein-2 (BMP-2) delivery for bone 
engineering. 
 
 
a: whole appearance of molar.  
b: divided tooth (E; enamel, D; dentin, P; pulp).  
c: crushed tooth granules.  
d: SEM photograph of calcified dentin after crushing and washing. Note; dentinal tubes 
Fig. 1. Human wisdom tooth 
2. Bone induction of human dentin 
In 1967, bone-inducing property in rabbit dentin was confirmed in the intramuscular 
pockets (Yeoman &Urist, 1967; Bang & Urist, 1967), after the discovery of bone induction by 
rabbit demineralized bone matrix (DBM) in 1965 (Urist, 1965). The rabbit studies reported 
that completely demineralized dentin matrix (DDM) induced bone at 4 weeks, while non-
demineralized dentin (so-called, calcified dentin) induced bone at 8-12 weeks after 
implantation (Yeoman & Urist, 1967). In our study, human DDM including small patches of 
cementum derived from wisdom teeth, and human DBM derived from adult femur induced 
bone and cartilage independently in the subcutaneous tissues at 4 weeks (Murata et al., 
2010a). The delayed inductive properties of the calcified dentin and bone may be related to 
the inhibition of BMP-release by the apatite crystals. Highly calcified tissues such as cortical 
bone and dentin are not earlier in osteoinduction and bone fornmation than spongy bone, 
decalcified bone (DBM), and decalcified dentin (DDM) (Huggins et al., 1970). 
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Dentin and bone are mineralized tissues and almost similar in chemical components. Both 
DDM and DBM are composed of predominantly type I collagen (95%) and the remaining as 
non-collagenous proteins including small amount of growth factors (Finkelman et al., 1990). 
In other words, DDM and DBM can be defined as acid-insoluble collagen binding bone 
morphogenetic proteins (BMPs), which are member of transforming growth factor-beta 
(TGF-β) super-family. BMPs were discovered from bone matrix (Urist, 1965; Sampath & 
Reddi., 1983), and had bone-inducing property in non-skeletal site (Murata et al., 1998). 
Animal dentin-derived BMPs were extracted with 4M guanidine HCl, and partially purified 
from rat, rabbit, and bovine (Butler et al., 1977; Urist & Mizutani, 1982; Kawai & Urist, 1989; 
Bessho et al, 1990). In addition, the concentration of TGF-β, Insulin growth factor-I (IGF-I) 
and Insulin growth factor-II (IGF-II) were detected in human dentin (DDM). Briefly, the 
three growth factors were measured in the following concentration (ng/μg 4M guanidine 
hydrochloride-EDTA protein): TGF-β (0.017), IGF-I (0.06) and IGF-II (0.52). All 3 growth 
factors were present in concentrations lower than that in human bone (Finkelman et al., 
1990). Recently, both mature and immature types of BMP-2 were detected in human dentin 
and dental pulps (Ito et al., 2008).  
 
 
a: SEM of DDM (granule size: 0.5mm), Note: smooth surface and no crack. 
b: bone induction by DDM at 4 weeks. 
c: SEM of DBM (granule size: 0.5mm), Note: micro-cracks and spaces of blood vessels. 
d: bone induction by DBM at 4 weeks. 
Fig. 2. Dematerialized dentin matrix (DDM) and dematerialized bone matrix (DBM) 
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Even after the demineralization of dentin, active types of BMPs bind collagen-rich matrices, 
similar to bone (Urist et al., 1973). The decalcified dentin (DDM) was known to be more active 
bone-inducing matrix than the calcified dentin (Yeoman & Urist, 1967), and roll type of 
decalcified dentin membrane revealed better activity of bone induction (Inoue et al., 1986).  
Very interestingly, the demineralized treatment for bone and dentin increased their 
osteoinductivity and decreased their antigenesity (Reddi, 1974). These facts are scientifically 
very important for the processing procedures of hard tissue-derived graft materials (Kim et 
al., 2010; Murata et al, 2010a). 
The acid-insoluble dentin matrix (DDM) after demineralization is an organic, absorbable 
material with original dentin structures. Human DDM, prepared from vital teeth-origin, 
were implanted into the subcutaneous tissue in 4 week-old nude mice, deficient in 
immunogenic reactions. The DDM induced bone and cartilage independently at 4 weeks 
after the subcutaneous implantation, similar to human DBM (Murata et al., 2010b). The 
independent differentiation of bone and cartilage was compatible to our previous study 
using ceramic and collagen combined with BMPs (Murata et al., 1998). The acid-insoluble 
collagen, DBM and DDM, possess the ability to coagulate platelet-free heparinized, citrated, 
and oxalated blood plasmas (Huggins & Reddi., 1973). Clotting constituents become 
denatured in contact with the insoluble coagulant proteins. The coagulation action of blood 
plasma by DBM and DDM should become advantageous for surgical operations. 
Collagenous materials has been commercially available as medical uses for more 30 years. 
3. Clinical study of human dentin 
3.1 Case 1: Bone augmentation, 48 year-old man 
First clinical study was reported at 81st IADR conference, Sweden in 2003 that DDM 
autograft had succeeded for bone augmentation (Murata et al., 2003).  
The aim of this pioneering study is to observe new bone formation in the tissues obtained 
from the dental implant-placed region after the DDM graft for sinus lifting.  
Patient 
A 48-year-old male presented with missing teeth (#24-#26, #45-#47). Clinical examinations 
revealed an atrophied upper jaw in the region (Fig. 3,4). His medical history was 
unremarkable.  
Surgical procedure 1 
Four teeth (#17,#18,#25,#28) were extracted and 2 molars (#17,#18) were stocked at -80℃ 
for DDM. His right occlusion was restored using dental implants as the first clinical step 
(Fig. 4b). 
Preparations of DDM 
The autogenous DDM were obtained from non-functional vital teeth (#17, #18) (Fig. 4a). The 
molars were crushed by hand-made under the cooling with liquid nitrogen. The crushed 
tooth granules were decalcified completely in 0.6N HCl solution. The DDM granules 
including cementum were extensively rinsed in cold distilled water, and then freeze-dried 
(Murata et al., 2010a).  
Surgical procedure 2 
Sinus lifting procedure was done using autogenous dry DDM for bone augmentation (Fig. 
3). At 5 months after the operation, 3 fixtures (FLIALIT-2®, FRIADENT) were implanted 
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into the augmented bone under local anesthesia (Fig. 4c). At the same time, bone biopsy was 
carried out for the tissue observation (Fig. 4d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a: intraoral initial view (before operation), Note: 3 missing teeth and atrophied maxilla. 
b: oval shaped window 
c: autogenous DDM derived from 2 molars 
d: view just after DDM autograft 
Fig. 3. Case 1: DDM autograft for sinus lifting, 48 year-old man 
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a: initial view, b: 4 months after DDM graft, c: dental implant placement, d: mature bone with marrow 
Fig. 4. X-ray photography and bone biopsy 
Results and discussion 
The biopsy tissue showed that mature bone was interconnected with the remained DDM 
granules (Fig. 4d). We found that DDM facilitated its adaption of the grafted site and was 
slowly absorbed as new bone began to form.  
Conclusion 
This patient was successfully restored with the dental implants after the DDM autograft. 
These results demonstrated that autogenous dentin could be recycled as an innovative 
biomaterial. 
3.2 Case 2: Bone regeneration, 58 year-old woman 
Patient 
A 58-year-old female presented with missing teeth (#12-#22). A clinical examination 
revealed an atrophied upper jaw in the section. Her medical history was unremarkable.  
Preparations of DDM 
The autogenous DDM were obtained from a non-functional vital tooth (#17). The second 
molar was crushed with saline ice by our newly developed tooth- mill (DENTMILL®, Tokyo 
Iken Co., Ltd) at 12000rpm for 30 sec (Fig. 5). Briefly, vessel and blade were made in ZrO2 , 
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which have gained the approval of Food and Drug Administration (FDA) for human use. 
The ZrO2 ceramics were fabricated by sintering at 1400℃ for 2 h after the slip casting of the 
mixture of ZrO2 powder and distilled water (Fig. 5a). As the results of characteristics 
analyses of ZrO2 objects, the contraction rate, the relative density, and the bending strength 
were 21%, 99%, and 400MPa, respectively. The automatic mill could crush a tooth and/or a 
cortical bone block (1x1x1cm3) under the condition of cooling using saline ice blocks (1cm3) 
(Fig. 5b). The crushed tooth granules were decalcified completely in 0.026N HNO3 solution 
for 20 min. The DDM granules including cementum were extensively rinsed in cold distilled 
water  (Fig. 5e),  (Murata et al., 2009; Murata et al., 2010a).  
 
 
a: ZrO2 vessel and blade, b: tooth with ice blocks, c: stainless cover, d: mill, e: DDM granules before 
clinical use. 
Fig. 5. Preparation of DDM using automatic tooth mill (DENTMILL®, Tokyo Iken) 
Surgical procedure 
Splitting osteotomy and cortical perforations were performed in the atrophied jaw and the 
autogenous DDM were transplanted to the treated bone in 2006 (Fig. 6a,b,c). At 4 months 
after the operation, 3 same fixtures (Synchro-steppted screw type: diameter; 3.4mm, length; 
11mm, FLIALIT-2® , FRIADENT) were implanted into the augmented bone under local 
anesthesia  (Fig. 6b). At the same time, bone biopsy was carried out for the tissue 
observation. 
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Results and discussion 
The biopsy tissue showed that DDM granules were received to host and the biological width 
(4-6mm) was acquired. The DDM residues were partially observed during the implant 
placement. Bone biopsy revealed the DDM were remodeled by bone at 4 months. This 
patient was successfully restored with the dental implants after the DDM autograft (Fig. 6d). 
Though animal-derived atelocollagens have been generally used as medical materials, 
autogenous decalcified dentin is a highly insoluble collagenous matrix and a safe 
biomaterial. 
Conclusion 
Human DDM granules from vital teeth are collagenous matrics with osteoinductive 
potency, and the human dentin can be recycled as autogenous biomaterials for local bone 
engineering.  
Case 1 and 2 were approved by the Ethical Committee in the Health Sciences University of 
Hokkaido. All subjects enrolled in this research have responded to an Informed Consent 
which has been approved by my Institutional Committee on Human Research and that this 
protocol has been found acceptable by them. 
 
 
a: 4 missing teeth and atrophied upper maxilla b: DDM autograft before suture c: just after operation d: 
final view after prosthetic restoration using dental implantation 
Fig. 6. Case 2: Bone regeneration, 58 year-old woman 
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4. Dentin scaffold for recombinant human BMP-2 
4.1 Recombinant human BMP products 
BMP-2, 4, and 7 are strong accelerating factors of bone induction. Currently, BMP-2 and 
BMP-7 have been shown in clinical studies to be beneficial in the therapy of a variety of 
bone-related conditions including delayed union and non-union. BMP-2 (Medtronic 
Co.Ltd.) and BMP-7 (Stryker Biotech Co.Ltd.) have received Food and Drug Administration 
(FDA) approval for human clinical uses (fractures of long bones, inter-vertebral disk 
regeneration), by delivery in purified collagen matrix or ceramics. Moreover, the BMP-2 
product has been approved for certain dental applications. BMP-7 has also found use in the 
treatment of chronic kidney disease. In 2002, Curis licensed BMP-7 to Ortho Biotech 
Products, a subsidiary of Johnson & Johnson. 
4.2 Acceleration of bone induction by BMP2 in human DDM scaffold 
The aim of the following study was to estimate the increase of the bone-inductive potency 
by DDM combined with BMP-2 in rat subcutaneous tissues.  
Composition of BMP-2 solution and DDM 
One hundred micro-liter of recombinant human BMP-2 solution (0.0, 0.5, 1.0, 2.0, 5.0μg of 
BMP-2) was mixed with 70 mg of human DDM in a sterilized syringe. The composite was 
called as the BMP-2/DDM. The DDM alone with 100μl of PBS was also prepared as a BMP-
free control. 
Bioassay in rats 
Wistar rats (male, 4 week-old) were subjected to intraperitoneal anesthesia and incisions 
were added to the back skin under the sterile conditions. Each animal received three BMP-
containing composites (BMP-2/DDM) and one BMP-free control (DDM alone). The 
implanted materials were removed at 3 weeks after implantation, and prepared for 
histomorphological examinations. All procedures were followed the Guidelines in Health 
Sciences University of Hokkaido for Experiments on Animals.  
Histological findings and Morphometric analysis at 3 weeks 
In the BMP-2 (5.0μg)/DDM (70mg) group, bone with hematopoietic bone marrow 
developed extensively at 3 weeks. Chondrocytes were found only in the BMP-2 (0.5, 
1.0μg)/DDM groups (Table 1). The BMP-2 (2.0, 5.0μg)/DDM groups accelarated bone 
induction predominantly (Fig. 7). In the DDM alone group, mesenchymal tissue was seen 
between DDM particles, and hard tissue induction was not observed at 3 weeks (Fig. 8). 
Morphometric analysis demonstrated that the volume of the induced bone and marrow 
increased at BMP-2 dose-dependent manner, while the DDM decreased at the dose-
dependent (Table 1). Briefly, the volume of the bone and marrow in BMP-2 (1.0μg)/DDM 
and BMP-2 (5.0μg)/DDM showed 3.7% and 26.3%, respectively. BMP-2 (0.5μg)/DDM 
showed 0.0% and 4.0% in the volume of bone and cartilage, respectively. 
Conclusion 
BMP-2 strongly accelerated bone formation in the DDM carrier system. DDM never 
inhibited BMP-2 activity and revealed better release profile of BMP-2. These results indicate 
that human recycled DDM are unique, absorbable matrix with osteoinductivity and the 
DDM should be an effective graft material as a carrier of BMP-2 delivering and a scaffold for 
bone-forming cells for bone engineering. 
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Induced bone (B) bridging between DDM (D) granules. Note: active osteoblast differentiation.  
Fig. 7. Photograph in BMP-2 (5.0μg)/DDM (70mg) at 3 weeks 
 
 
Fibroblasts on surface of DDM granule with original dentinal tubes. 
Fig. 8. Photograph in DDM (70mg) alone at 3 weeks 
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Dose of BMP-2  ( μg ) 
0 0.5 1 2 5 
bone 0 0 3.7 ± 1.41 7.4 ± 0.94 20.3 ± 4.64 
cartilage 0 4.0 ± 0.81 2.3 ± 0.47 0 0 
bone marrow 0 0 0 0 6.0 ± 1.63 
DDM 57.0 ± 0.81 43.3 ± 3.39 41.0 ± 2.16 40.3 ± 1.69 37.0 ± 0.81 
mesenchymal tissue 40.7 ± 0.94 49.0 ± 5.09 48.0 ± 3.85 46.0 ± 2.16 32.7 ± 5.73 
connective tissue 2.3 ± 0.47 3.7 ± 1.24 5.0 ± 0.47 6.3 ± 0.47 4.0 ± 0.81 
All tissue: 100 % , values: mean ± SD , N: 9, Explanted time: 3 weeks 
The volume of bone and marrow showing a dose-dependent increase. 
The volume of DDM showing a dose-dependent decrease. 
Table 1. Morphometry of BMP-2 dose-dependent study. 
5. Material science for patients in the near future 
Biomaterials have had a major impact on the regenerative medicine and patient care for 
improving the quality of lives of human.  
We have been challenging to be able to develop bioabsorbable materials, harmonized with 
living body, especially bone remodelling, using an innovative supersonic and acid-etching 
technology (Akazawa et al. 2010). Implanted biomaterials first contact to body fluid and 
cells. Human cells never live in dry condition. Generally, organ and tissue have 
interconnected porous structure for dynamic flow of body fluid. Material walls inhibit the 
body fluid permeation and the cell invasion. Therefore, we focused on the permeability of 
body fluid into the bulk of materials and the biomimetic structure for the living and 
working cells  (Murata et al., 2007). Body fluid can permeate into collagenous materials such 
as DDM and DBM. Novel DDM material  contains native growth factors, and adsorbs 
several proteins derived from body fluid. In addition, DDM with RGD sequences supports 
mesenchymal cell adhesion as anchorage matrix. 
Most importantly, material scientists, engineers, and doctors must work together and 
cooperate as professionals for the development of functional materials and for the present 
and future of all patients. 
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